On May 14 2024, Jill represented the Division of BioTherapeutics in the annual LACDR Spring Symposium and presented her research on age-associated B cells in atherosclerosis. The LACDR Spring Symposium is attended by ~150 LACDR employees. In addition, master students of BioPharmaceutical Sciences attend this Symposium to learn about our research and for whom this is a training activity.